Human β-adrenergic receptor kinase polypeptide and methods
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 11, 2012
Issued Date -
N/A
app pub date -
Sep 20, 2010
filing date -
Apr 30, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully